Louise Fanchon, PhD (2+2)
Louise Fanchon graduated from the University of Western Brittany, France with a PhD degree in image processing and analysis and entered Memorial Sloan Kettering’s Medical Physics Residency program in 2016. At Memorial Sloan Kettering, she is performing research under the supervision of John Humm, Chief of the Imaging Physics section. Dr. Fanchon’s research interests include molecular and nuclear imaging techniques to quantify drug distribution, PET guided biopsy, and PET imaging of radionuclides relevant to targeted radio-therapy.
Yiming Gao, PhD (2+2)
Yiming Gao graduated from Rensselaer Polytechnic Institute with a PhD degree in Nuclear Engineering and entered the Medical Physics Residency program of Memorial Sloan Kettering Cancer Center in 2016. At MSKCC, he is performing research under the supervision of Dr. Lawrence Dauer, Corporate Radiation Safety Officer and head of the Medical Health Physics group of the Medical Physics Department. Dr. Gao’s research focuses on radiation dosimetry study in CT, PET/CT, interventional fluoroscopy, and cone-beam CT.
Xingyu Nie, PhD (2+2)
Xingyu Nie received his PhD degree in biomedical engineering from Washington University in St. Louis with a thesis on PET/MR imaging of atherosclerosis in 2017. He joined the medical physics residency program of Memorial Sloan-Kettering Cancer Center afterwards and conducted postdoctoral research under the supervision of Dr. George (Guang) Li and Dr. Joseph Deasy. Dr. Nie’s research interests at MSKCC focus on the development of time-resolved 4DMRI techniques for motion simulation in radiotherapy treatment planning.
Mohamad Sadegh Riyahi Alam, PhD
Sadegh Riyahi-Alam received PhD degree in Biomedical engineering with a specialty in medical image analysis using deformable image registration. He started a postdoctoral position at Memorial Sloan Kettering in 2016 and was mainly involved in quantitative evaluation of tumor response to chemo-radiation therapy and prediction of clinical outcome in longitudinal applications. He joined 2+2 medical physics residency program in 2019 and currently working on minimizing normal tissue toxicity for adaptive radiotherapy and predictive treatment planning.